Literature DB >> 16359528

Bridging anticoagulation for patients on long-term vitamin-K-antagonists. A prospective 1 year registry of 311 episodes.

K M Halbritter, A Wawer, J Beyer, W Oettler, S M Schellong.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16359528     DOI： 10.1111/j.1538-7836.2005.01674.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  13 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  [Bridging anticoagulation].

Authors:  S M Schellong; K Halbritter; S Haas
Journal:  Chirurg       Date:  2007-02       Impact factor: 0.955

3.  Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study.

Authors:  Amparo Santamaría; Arantxa Ugarriza; Carmen Muñoz; Isabel De Diego; Francisca López-Chulia; Carmen Benet; Javier Martínez-González; Natividad Gómez; Elena Pina; Xavier Ortín; Pascual Marco; Franciso Javier Roncalés; Jordi Fontcuberta
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

4.  Perioperative management of patients who are receiving a novel oral anticoagulant.

Authors:  Aaron Liew; James Douketis
Journal:  Intern Emerg Med       Date:  2013-06-27       Impact factor: 3.397

Review 5.  [Perioperative management of anticoagulation].

Authors:  R Eisele; N Melzer; P Bramlage
Journal:  Chirurg       Date:  2014-06       Impact factor: 0.955

6.  Predictors of perioperative major bleeding in patients who interrupt warfarin for an elective surgery or procedure: Analysis of the BRIDGE trial.

Authors:  Nathan P Clark; James D Douketis; Vic Hasselblad; Sam Schulman; Andrei L Kindzelski; Thomas L Ortel
Journal:  Am Heart J       Date:  2017-09-21       Impact factor: 4.749

7.  [Periprocedual management of vitamin K antagonist's with low molecular weight heparins during invasive procedures--Consensus of experts].

Authors:  Herbert Watzke; Helfried Metzler; Ansgar Weltermann; Peter Marschang; Marianne Brodmann; Wilfried Lang; Ingrid Pabinger-Fasching; Elisabeth Mahla; Sibylle Kozek-Langenecker; Michael Guschmann; Kurt Huber
Journal:  Wien Klin Wochenschr       Date:  2013-07       Impact factor: 1.704

8.  Low molecular weight heparin bridging for atrial fibrillation: is VTE thromboprophylaxis the major benefit?

Authors:  Henny H Billett; Barbara A Scorziello; Emily R Giannattasio; Hillel W Cohen
Journal:  J Thromb Thrombolysis       Date:  2010-11       Impact factor: 2.300

9.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.

Authors:  James D Douketis; Alex C Spyropoulos; Scott Kaatz; Richard C Becker; Joseph A Caprini; Andrew S Dunn; David A Garcia; Alan Jacobson; Amir K Jaffer; David F Kong; Sam Schulman; Alexander G G Turpie; Vic Hasselblad; Thomas L Ortel
Journal:  N Engl J Med       Date:  2015-06-22       Impact factor: 91.245

Review 10.  [Platelet aggregation inhibitors and anticoagulants during ophthalmic interventions].

Authors:  N Feltgen; H Hoerauf; W Noske; A Hager; J Koscielny
Journal:  Ophthalmologe       Date:  2016-12       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.